General MedicationsORAL-28Standard

DESOGESTREL AND ETHINYL ESTRADIOL

DESOGESTREL; ETHINYL ESTRADIOL

Standard Dose

0.15MG,N/A;0.02MG,0.01MG

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview DESOGESTREL AND ETHINYL ESTRADIOL is listed in Drugs@FDA under application 209170 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient DESOGESTREL; ETHINYL ESTRADIOL Form and strength TABLET;ORAL-28 - 0.15MG,N/A;0.02MG,0.01MG Sponsor NAARI PTE Submission history Latest submission status date: 2017-06-05 00:00:00.

Structured Monograph

Clinical summary

Approval overview DESOGESTREL AND ETHINYL ESTRADIOL is listed in Drugs@FDA under application 209170 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient DESOGESTREL; ETHINYL ESTRADIOL Form and strength TABLET;ORAL-28 - 0.15MG,N/A;0.02MG,0.01MG Sponsor NAARI PTE Submission history Latest submission status date: 2017-06-05 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.